3 stories tagged #CAR-T

  1. Lymphocyte Growth Rate Key Predictor for CAR-T Therapy Success in Lymphoma
    health

    Lymphocyte Growth Rate Key Predictor for CAR-T Therapy Success in Lymphoma

    New research reveals lymphocyte expansion speed post-CAR-T therapy is a critical biomarker for predicting survival and toxicity in lymphoma patients.

    last mo. 1 min read
  2. CAR-T Therapy Demonstrates Significant Progress in Stiff Person Syndrome Study
    health

    CAR-T Therapy Demonstrates Significant Progress in Stiff Person Syndrome Study

    Pivotal Phase II KYSA-8 study presented at AAN 2026 shows CAR-T therapy miv-cel offers substantial clinical improvements for Stiff Person Syndrome patients.

    last mo. 1 min read
  3. Eli Lilly Acquires Kelonia Therapeutics for Up to $7 Billion in Cancer Therapy Push
    health

    Eli Lilly Acquires Kelonia Therapeutics for Up to $7 Billion in Cancer Therapy Push

    Eli Lilly announces a major acquisition of Kelonia Therapeutics for up to $7 billion, bolstering its cell therapy pipeline with a novel in vivo cancer treatment.

    last mo. 1 min read